Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Helena Krmac is active.

Publication


Featured researches published by Helena Krmac.


Journal of Biological Chemistry | 2010

Parkinson Disease-associated DJ-1 Is Required for the Expression of the Glial Cell Line-derived Neurotrophic Factor Receptor RET in Human Neuroblastoma Cells

Rossana Foti; Silvia Zucchelli; Marta Biagioli; Paola Roncaglia; Sandra Vilotti; Raffaella Calligaris; Helena Krmac; Javier Enrique Girardini; Giannino Del Sal; Stefano Gustincich

Mutations in PARK7/DJ-1 are associated with autosomal recessive, early onset Parkinson disease (PD). DJ-1 is an atypical peroxiredoxin-like peroxidase that may act as a redox-dependent chaperone and a regulator of transcription. Here we show that DJ-1 plays an essential role in the expression of rearranged during transfection (RET), a receptor for the glial cell line-derived neurotrophic factor, a neuroprotective molecule for dopaminergic neurons, the main target of degeneration in PD. The inducible loss of DJ-1 triggers the establishment of hypoxia and the production of reactive oxygen species that stabilize the hypoxia-inducible factor-1α (HIF-1a). HIF-1a expression is required for RET down-regulation. This study establishes for the first time a molecular link between the lack of functional DJ-1 and the glial cell line-derived neurotrophic factor signaling pathway that may explain the adult-onset loss of dopaminergic neurons. Furthermore, it suggests that hypoxia may play an important role in PD.


BMC Genomics | 2009

A transcriptome analysis identifies molecular effectors of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells

Raffaella Calligaris; Cristina Bellarosa; Rossana Foti; Paola Roncaglia; Pablo Giraudi; Helena Krmac; Claudio Tiribelli; Stefano Gustincich

BackgroundThe deposition of unconjugated bilirubin (UCB) in selected regions of the brain results in irreversible neuronal damage, or Bilirubin Encephalopathy (BE). Although UCB impairs a large number of cellular functions in other tissues, the basic mechanisms of neurotoxicity have not yet been fully clarified. While cells can accumulate UCB by passive diffusion, cell protection may involve multiple mechanisms including the extrusion of the pigment as well as pro-survival homeostatic responses that are still unknown.ResultsTranscriptome changes induced by UCB exposure in SH-SY5Y neuroblastoma cell line were examined by high density oligonucleotide microarrays. Two-hundred and thirty genes were induced after 24 hours. A Gene Ontology (GO) analysis showed that at least 50 genes were directly involved in the endoplasmic reticulum (ER) stress response. Validation of selected ER stress genes is shown by quantitative RT-PCR. Analysis of XBP1 splicing and DDIT3/CHOP subcellular localization is presented.ConclusionThese results show for the first time that UCB exposure induces ER stress response as major intracellular homeostasis in surviving neuroblastoma cells in vitro.


BMC Genomics | 2009

Fibroblasts from patients with Diamond-Blackfan anaemia show abnormal expression of genes involved in protein synthesis, amino acid metabolism and cancer

Federica Avondo; Paola Roncaglia; Nicoletta Crescenzio; Helena Krmac; Emanuela Garelli; Marta Armiraglio; Carlotta Castagnoli; Maria Francesca Campagnoli; Ugo Ramenghi; Stefano Gustincich; Claudio Santoro; Irma Dianzani

BackgroundDiamond-Blackfan anaemia (DBA) is a rare inherited red cell hypoplasia characterised by a defect in the maturation of erythroid progenitors and in some cases associated with malformations. Patients have an increased risk of solid tumors. Mutations have been found in several ribosomal protein (RP) genes, i.e RPS19, RPS24, RPS17, RPL5, RPL11, RPL35A. Studies in haematopoietic progenitors from patients show that haplo-insufficiency of an RP impairs rRNA processing and ribosome biogenesis. DBA lymphocytes show reduced protein synthesis and fibroblasts display abnormal rRNA processing and impaired proliferation.ResultsTo evaluate the involvement of non-haematopoietic tissues in DBA, we have analysed global gene expression in fibroblasts from DBA patients compared to healthy controls. Microarray expression profiling using Affymetrix GeneChip Human Genome U133A 2.0 Arrays revealed that 421 genes are differentially expressed in DBA patient fibroblasts. These genes include a large cluster of ribosomal proteins and factors involved in protein synthesis and amino acid metabolism, as well as genes associated to cell death, cancer and tissue development.ConclusionThis analysis reports for the first time an abnormal gene expression profile in a non-haematopoietic cell type in DBA. These data support the hypothesis that DBA may be due to a defect in general or specific protein synthesis.


European Journal of Neuroscience | 2010

Gene expression analysis of the emergence of epileptiform activity after focal injection of kainic acid into mouse hippocampus.

Dario Motti; Caroline Le Duigou; Emmanuel Eugène; Nicole Chemaly; Lucia Wittner; Dejan Lazarevic; Helena Krmac; Troels Torben Marstrand; Eivind Valen; Remo Sanges; Elia Stupka; Albin Sandelin; Enrico Cherubini; Stefano Gustincich; Richard Miles

We report gene profiling data on genomic processes underlying the progression towards recurrent seizures after injection of kainic acid (KA) into the mouse hippocampus. Focal injection enabled us to separate the effects of proepileptic stimuli initiated by KA injection. Both the injected and contralateral hippocampus participated in the status epilepticus. However, neuronal death induced by KA treatment was restricted to the injected hippocampus, although there was some contralateral axonal degeneration. We profiled gene expression changes in dorsal and ventral regions of both the injected and contralateral hippocampus. Changes were detected in the expression of 1526 transcripts in samples from three time‐points: (i) during the KA‐induced status epilepticus, (ii) at 2 weeks, before recurrent seizures emerged, and (iii) at 6 months after seizures emerged. Grouping genes with similar spatio‐temporal changes revealed an early transcriptional response, strong immune, cell death and growth responses at 2 weeks and an activation of immune and extracellular matrix genes persisting at 6 months. Immunostaining for proteins coded by genes identified from array studies provided evidence for gliogenesis and suggested that the proteoglycan biglycan is synthesized by astrocytes and contributes to a glial scar. Gene changes at 6 months after KA injection were largely restricted to tissue from the injection site. This suggests that either recurrent seizures might depend on maintained processes including immune responses and changes in extracellular matrix proteins near the injection site or alternatively might result from processes, such as growth, distant from the injection site and terminated while seizures are maintained.


BMC Medical Genomics | 2013

Genome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathways

Cecilia Mancini; Paola Roncaglia; Alessandro Brussino; Giovanni Stevanin; Nicola Lo Buono; Helena Krmac; Francesca Maltecca; Elena Gazzano; Anna Bartoletti Stella; Maria Antonietta Calvaruso; Luisa Iommarini; Claudia Cagnoli; Sylvie Forlani; Isabelle Le Ber; Alexandra Durr; Alexis Brice; Dario Ghigo; Giorgio Casari; Anna Maria Porcelli; Ada Funaro; Giuseppe Gasparre; Stefano Gustincich

BackgroundSCA28 is an autosomal dominant ataxia associated with AFG3L2 gene mutations. We performed a whole genome expression profiling using lymphoblastoid cell lines (LCLs) from four SCA28 patients and six unrelated healthy controls matched for sex and age.MethodsGene expression was evaluated with the Affymetrix GeneChip Human Genome U133A 2.0 Arrays and data were validated by real-time PCR.ResultsWe found 66 genes whose expression was statistically different in SCA28 LCLs, 35 of which were up-regulated and 31 down-regulated. The differentially expressed genes were clustered in five functional categories: (1) regulation of cell proliferation; (2) regulation of programmed cell death; (3) response to oxidative stress; (4) cell adhesion, and (5) chemical homeostasis. To validate these data, we performed functional experiments that proved an impaired SCA28 LCLs growth compared to controls (p < 0.005), an increased number of cells in the G0/G1 phase (p < 0.001), and an increased mortality because of apoptosis (p < 0.05). We also showed that respiratory chain activity and reactive oxygen species levels was not altered, although lipid peroxidation in SCA28 LCLs was increased in basal conditions (p < 0.05). We did not detect mitochondrial DNA large deletions. An increase of TFAM, a crucial protein for mtDNA maintenance, and of DRP1, a key regulator of mitochondrial dynamic mechanism, suggested an alteration of fission/fusion pathways.ConclusionsWhole genome expression profiling, performed on SCA28 LCLs, allowed us to identify five altered functional categories that characterize the SCA28 LCLs phenotype, the first reported in human cells to our knowledge.


PLOS ONE | 2016

Whole Blood Gene Expression Profiling in Preclinical and Clinical Cattle Infected with Atypical Bovine Spongiform Encephalopathy

Elena Xerxa; Maura Barbisin; Maria Novella Chieppa; Helena Krmac; Elena Vallino Costassa; Paolo Vatta; Marion M. Simmons; Maria Caramelli; Cristina Casalone; Cristiano Corona; Giuseppe Legname

Prion diseases, such as bovine spongiform encephalopathies (BSE), are transmissible neurodegenerative disorders affecting humans and a wide variety of mammals. Variant Creutzfeldt-Jakob disease (vCJD), a prion disease in humans, has been linked to exposure to BSE prions. This classical BSE (cBSE) is now rapidly disappearing as a result of appropriate measures to control animal feeding. Besides cBSE, two atypical forms (named H- and L-type BSE) have recently been described in Europe, Japan, and North America. Here we describe the first wide-spectrum microarray analysis in whole blood of atypical BSE-infected cattle. Transcriptome changes in infected animals were analyzed prior to and after the onset of clinical signs. The microarray analysis revealed gene expression changes in blood prior to the appearance of the clinical signs and during the progression of the disease. A set of 32 differentially expressed genes was found to be in common between clinical and preclinical stages and showed a very similar expression pattern in the two phases. A 22-gene signature showed an oscillating pattern of expression, being differentially expressed in the preclinical stage and then going back to control levels in the symptomatic phase. One gene, SEL1L3, was downregulated during the progression of the disease. Most of the studies performed up to date utilized various tissues, which are not suitable for a rapid analysis of infected animals and patients. Our findings suggest the intriguing possibility to take advantage of whole blood RNA transcriptional profiling for the preclinical identification of prion infection. Further, this study highlighted several pathways, such as immune response and metabolism that may play an important role in peripheral prion pathogenesis. Finally, the gene expression changes identified in the present study may be further investigated as a fingerprint for monitoring the progression of disease and for developing targeted therapeutic interventions.


International Conference on Spinocerebellar degenerations - SPATAX | 2013

Genome-wide expression analysis identified defects in cell growth, proliferation and viability in SCA28 lymphoblastoid cell lines.

Cecilia Mancini; Paola Roncaglia; Alessandro Brussino; Giovanni Stevanin; Nicola Lo Buono; Helena Krmac; Francesca Maltecca; Elena Gazzano; A Bartoletti Stella; Maria Antonietta Calvaruso; Luisa Iommarini; Claudia Cagnoli; Sylvie Forlani; I Le Ber; Alexandra Durr; Alexis Brice; Dario Ghigo; Giorgio Casari; Am Porcelli; Ada Funaro; Giuseppe Gasparre; Stefano Gustincich


XV Congresso Nazionale Società Italiana di Genetica Umana (SIGU) | 2012

Studio dei meccanismi patogenetici dell’Atassia Spinocerebellare tipo 28.

Cecilia Mancini; Paola Roncaglia; N Lo Buono; Elena Gazzano; A Bartoletti Stella; E Mariani; Maria Antonietta Calvaruso; Luisa Iommarini; Alessandro Brussino; Claudia Cagnoli; Helena Krmac; Giovanni Stevanin; Sylvie Forlani; Ada Funaro; Alexandra Durr; Anna Maria Porcelli; Dario Ghigo; Giuseppe Gasparre; Stefano Gustincich


XV Congresso Nazionale SIGU Società Italiana di Genetica Umana | 2012

Identification of pathogenic mechanisms of Spinocerebellar Ataxia, type 28 (SCA28).

Cecilia Mancini; Paola Roncaglia; N Lo Buono; Elena Gazzano; A Bartoletti Stella; E Mariani; Maria Antonietta Calvaruso; Luisa Iommarini; Alessandro Brussino; Claudia Cagnoli; Helena Krmac; Giovanni Stevanin; Sylvie Forlani; Ada Funaro; Alexandra Durr; Anna Maria Porcelli; Dario Ghigo; Giuseppe Gasparre; Stefano Gustincich


D-Day 2012 | 2012

Studio dei meccanismi patogenetici dell’Atassia Spinocerebellare 28.

Cecilia Mancini; Paola Roncaglia; N. Lo Buono; Elena Gazzano; Alessandro Brussino; Claudia Cagnoli; Helena Krmac; Giovanni Stevanin; Sylvie Forlani; Eriola Hoxha; Ada Funaro; Alexandra Durr; Filippo Tempia; F. Altruda; E. Turco; Dario Ghigo; Stefano Gustincich

Collaboration


Dive into the Helena Krmac's collaboration.

Top Co-Authors

Avatar

Stefano Gustincich

International School for Advanced Studies

View shared research outputs
Top Co-Authors

Avatar

Paola Roncaglia

International School for Advanced Studies

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge